Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with Chemoradiation for PCNSL
NCT00455286Phase 2Unknown
- Sponsor
- National Health Research Institutes
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in primary central nervous system lymphoma (PCNSL), sponsored by National Health Research Institutes. Status: unknown.
02
Drugs
temozolomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00455286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455286.